E'ville Biz: Wareham Pitches New Overland Campus; UPSIDE in Legal Battle with Co-Founder; Zymergen, Amyris & Gritstone Pursuing Covid-19 Vaccines - The E'ville Eye Community News
M&A Strategy Update
What do you guys think about Zymergen? I am quite bullish, but please prove me wrong. The company has $100m market cap and $300m cash in the bank and hiring 60 people (
As Zymergen Inc.'s market cap (NASDAQ:ZY) drops to US$425m, insiders might be questioning their decision to buy earlier this year | Nasdaq
Randy Gwirtzman & Laird Bieger: Our Best Small-Cap Ideas
Zymergen Patents - Insights & Stats
Zymergen Patents - Insights & Stats
What You Need To Know About Zymergen Inc.'s (NASDAQ:ZY) Investor Composition
Zymergen Stock: Upcoming Ginkgo Bioworks Acquisition (NASDAQ:ZY) | Seeking Alpha
Ginkgo Buys Embattled Biotech Firm Zymergen For Paltry $300 Million
Zymergen
Varro Analytics on X: "DISCUSSION THREAD Topic: $SRNGU/ $SRNG and potential Ginkgo Bioworks SPAC deal. Specifically, $20B valuation mentioned by Bloomberg Will walk through some mkt data on chart below Comments encouraged #
Zymergen Stock: Upcoming Ginkgo Bioworks Acquisition (NASDAQ:ZY) | Seeking Alpha
Zymergen (ZY) plunges 68% on forecast for 'immaterial' revenue in 2022
Ginkgo Bioworks Completes Acquisition of Zymergen
Alexander Schanne auf LinkedIn: Ginkgo to Acquire Zymergen
logo_zymergen.jpg
What You Need To Know About Zymergen Inc.'s (NASDAQ:ZY) Investor Composition
Zymergen (ZY) plunges 68% on forecast for 'immaterial' revenue in 2022
Biofacturing' company Zymergen's stock plunges about 70% - MarketWatch
Zymergen Inc Share Price Today | NASDAQ ZY Stock - Investing.com India
Zymergen Stock: Upcoming Ginkgo Bioworks Acquisition (NASDAQ:ZY) | Seeking Alpha
Why Shares of Zymergen Plunged 62% in August | The Motley Fool
Biotech from bust to boom
Why Shares of Zymergen Plunged 62% in August | The Motley Fool
E'ville Biz: Novartis shifting Pharma jobs to Emeryville Campus, Zymergen raises $130MM, Ex'pression College becomes SAE - The E'ville Eye Community News
Why Zymergen Stock Sank Today | The Motley Fool
